EGFR-mutated non-small-cell lung cancer transformation into small-cell lung cancer after tyrosine kinase inhibitors: let us think about liquid biopsy!

被引：0
|
作者：
Pezzuto, F. [1 ]
Fortarezza, F. [1 ]
Lunardi, F. [1 ]
Tauro, V. [1 ]
Frega, S. [1 ]
Pasello, G. [1 ]
Calabrese, F. [1 ]
机构：
[1] Univ Padua, Padua, Italy
来源：
VIRCHOWS ARCHIV | 2021年 / 479卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-23-003
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 50 条
  • [1] Rociletinib in EGFR-Mutated Non-Small-Cell Lung Cancer
    Sequist, L. V.
    Soria, J-C
    Goldman, J. W.
    Wakelee, H. A.
    Gadgeel, S. M.
    Varga, A.
    Papadimitrakopoulou, V.
    Solomon, B. J.
    Oxnard, G. R.
    Dziadziuszko, R.
    Aisner, D. L.
    Doebele, R. C.
    Galasso, C.
    Garon, E. B.
    Heist, R. S.
    Logan, J.
    Neal, J. W.
    Mendenhall, M. A.
    Nichols, S.
    Piotrowska, Z.
    Wozniak, A. J.
    Raponi, M.
    Karlovich, C. A.
    Jaw-Tsai, S.
    Isaacson, J.
    Despain, D.
    Matheny, S. L.
    Rolfe, L.
    Allen, A. R.
    Camidge, D. R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (18): : 1700 - 1709
  • [2] The immune profile of EGFR-mutated non-small-cell lung cancer at disease onset and progression after tyrosine kinase inhibitors therapy
    Fumagalli, Caterina
    Guerini-Rocco, Elena
    Vacirca, Davide
    Passaro, Antonio
    de Marinis, Filippo
    Barberis, Massimo
    IMMUNOTHERAPY, 2018, 10 (12) : 1041 - 1045
  • [3] Adjuvant Osimertinib in EGFR-Mutated Non-Small-Cell Lung Cancer
    Planchard, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (18): : 1780 - 1782
  • [4] Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer
    Wu, Yi-Long
    Tsuboi, Masahiro
    He, Jie
    John, Thomas
    Grohe, Christian
    Majem, Margarita
    Goldman, Jonathan W.
    Laktionov, Konstantin
    Kim, Sang-We
    Kato, Terufumi
    Vu, Huu-Vinh
    Lu, Shun
    Lee, Kye-Young
    Akewanlop, Charuwan
    Yu, Chong-Jen
    de Marinis, Filippo
    Bonanno, Laura
    Domine, Manuel
    Shepherd, Frances A.
    Zeng, Lingmin
    Hodge, Rachel
    Atasoy, Ajlan
    Rukazenkov, Yuri
    Herbst, Roy S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (18): : 1711 - 1723
  • [5] Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung Cancer
    Mambetsariev, Isa
    Arvanitis, Leonidas
    Fricke, Jeremy
    Pharaon, Rebecca
    Baroz, Angel R.
    Afkhami, Michelle
    Koczywas, Marianna
    Massarelli, Erminia
    Salgia, Ravi
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)
  • [6] Rociletinib in EGFR-Mutated Non-Small-Cell Lung Cancer REPLY
    Sequist, Lecia V.
    Rolfe, Lindsey
    Allen, Andrew R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (06): : 578 - 579
  • [7] Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer?
    Roviello, Giandomenico
    Zanotti, Laura
    Cappelletti, Maria Rosa
    Gobbi, Angela
    Dester, Martina
    Paganini, Giovanni
    Pacifico, Chiara
    Generali, Daniele
    Roudi, Raheleh
    CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 18 (01) : 15 - 20
  • [8] Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer?
    Giandomenico Roviello
    Laura Zanotti
    Maria Rosa Cappelletti
    Angela Gobbi
    Martina Dester
    Giovanni Paganini
    Chiara Pacifico
    Daniele Generali
    Raheleh Roudi
    Clinical and Experimental Medicine, 2018, 18 : 15 - 20
  • [9] Genetic evolution to tyrosine kinase inhibitory therapy in patients with EGFR-mutated non-small-cell lung cancer
    Martinez-Marti, Alex
    Felip, Enriqueta
    Mancuso, Francesco Mattia
    Caratu, Ginevra
    Matito, Judit
    Nuciforo, Paolo
    Sansano, Irene
    Diaz-Mejia, Nely
    Cedres, Susana
    Callejo, Ana
    Iranzo, Patricia
    Pardo, Nuria
    Miquel, Josep Maria
    Navarro, Alejandro
    Vivancos, Ana
    Sanso, Miriam
    BRITISH JOURNAL OF CANCER, 2021, 125 (11) : 1561 - 1569
  • [10] Genetic evolution to tyrosine kinase inhibitory therapy in patients with EGFR-mutated non-small-cell lung cancer
    Alex Martinez-Marti
    Enriqueta Felip
    Francesco Mattia Mancuso
    Ginevra Caratú
    Judit Matito
    Paolo Nuciforo
    Irene Sansano
    Nely Diaz-Mejia
    Susana Cedrés
    Ana Callejo
    Patricia Iranzo
    Nuria Pardo
    Josep Maria Miquel
    Alejandro Navarro
    Ana Vivancos
    Miriam Sansó
    British Journal of Cancer, 2021, 125 : 1561 - 1569
12345